-
Aug 2009
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.
Clin ImmunolHerold KC, Gitelman S, Greenbaum CJ, Puck J, Hagopian WA, Gottlieb PA, Sayre PH, Bianchine PJ, Wong E, Seyfert-Margolis V, Bourcier K, Bluestone JA, Immune Tolerance Network ITN007AI Study Group. -
Jul 2009
The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis.
J Clin Endocrinol MetabMa X, Becker D, Arena VC, Vicini P, Greenbaum CJ -
Dec 2008
Type 1 Diabetes TrialNet--an international collaborative clinical trials network.
Ann N Y Acad SciSkyler JS, Greenbaum CJ, Lachin JM, Leschek E, Rafkin-Mervis L, Savage P, Spain L, Type 1 Diabetes TrialNet Study Group. -
Nov 2008
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
J ImmunolSchneider A, Rieck M, Sanda S, Pihoker C, Greenbaum CJ, Buckner JH -
Oct 2008
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Diabetes CareGreenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H, Type 1 Diabetes Trial Net Research Group., European C-Peptide Trial Study Group. -
Aug 2008
CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope.
J AutoimmunYang J, Danke N, Roti M, Huston L, Greenbaum CJ, Pihoker C , James EA, Kwok WW -
Aug 2008
Type 1 diabetes mellitus: primary, secondary, and tertiary prevention.
Mt Sinai J MedBollyky J, Sanda S, Greenbaum CJ -
Jul 2008
Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study.
Arch Pediatr Adolesc MedNaughton MJ, Ruggiero AM, Lawrence JM, Imperatore G, Klingensmith GJ, Waitzfelder B, McKeown RE, Standiford DA, Liese AD, Loots B, SEARCH for Diabetes in Youth Study Group., Greenbaum CJ -
Jun 2008
Standardization of C-peptide measurements.
Clin ChemLittle RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, Myers GL, Greenbaum CJ, Palmer JP, Rogatsky E, Stein DT -
Apr 2008
Use of oral glucose minimal model-derived index of insulin sensitivity in subjects with early type 1 diabetes mellitus.
MetabolismKrudys KM, Greenbaum CJ, Pihoker C, Vicini P -
Mar 2008
A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.
Diabetes CareSosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group. -
Oct 2007
Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes.
J ImmunolRieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum CJ, Concannon P, Buckner JH -
Sep 2007
Role of insulin resistance in predicting progression to type 1 diabetes.
Diabetes CareXu P, Cuthbertson D, Greenbaum CJ, Palmer JP, Krischer JP, Diabetes Prevention Trial Type 1 Study Group. -
Aug 2007
Editorial: The role of glucagon in postprandial hyperglycemia--the jury's still out.
J Clin Endocrinol MetabBollyky J, Greenbaum CJ -
Apr 2007
International comparison of C-peptide measurements.
Clin ChemWiedmeyer HM, Polonsky KS, Myers GL, Little RR, Greenbaum CJ, Goldstein DE, Palmer JP
